Montana Chapter of the American College of Cardiology

Eagleâ€™s Eye View: Your Weekly CV Update from ACC.org (Week of Nov. 21)
In this weekâ€™s View, Dr. Eagle discusses trends in the use of oral anticoagulants in older adults with newly diagnosed atrial fibrillation, then looks at a collaborative meta-analysis of large placebo-controlled trials that examines the impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes.
SGLT2 Inhibitors and Outcomes After Ablation for Atrial Fibrillation
What are the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on atrial fibrillation (AF) after catheter ablation?
Practical Approach to Left Main Coronary Artery Disease: Key Points
The following are key points to remember from this state-of-the-art review on a practical approach to left main (LM) coronary artery disease (CAD).
Effect of Ultrasound-Based Renal Denervation at 6 Months
What are the blood pressure (BP) effects and how safe is ultrasound renal denervation (uRDN) versus sham at 6 months in conjunction with escalating antihypertensive medications?
Patient Selection for Long-Term Secondary Prevention With Ticagrelor
Which patients with prior myocardial infarction (MI) on aspirin are most likely to have a favorable riskâ€“benefit profile with long-term ticagrelor?